Author:
Niitsu Tomihisa,Yasui-Furukori Norio,Inada Ken,Kanazawa Tetsufumi,Iyo Masaomi,Ueno Takefumi,Hashimoto Ryota
Funder
Ministry of Health, Labour and Welfare
Subject
Biological Psychiatry,Psychiatry and Mental health
Reference28 articles.
1. The history of clozapine and its emergence in the US market: a review and analysis;Crilly;Hist. Psychiatry,2007
2. Non-chemotherapy drug-induced neutropenia: key points to manage the challenges;Curtis;Hematology Am. Soc. Hematol. Educ. Program,2017
3. Adverse drug reactions and their fatal outcomes in clozapine patients in VigiBase: comparing the top four reporting countries (US, UK, Canada and Australia);De Las Cuevas;Schizophr. Res.,2023
4. Clozapine and the risk of haematological malignancies;de Leon;Lancet Psychiatry,2022
5. Improving the quality of web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES);Eysenbach;J. Med. Internet Res.,2004